Cargando…
Successful closure of ileostomy in a patient with intestinal Behçet's disease after therapy with adalimumab: A case report
RATIONALE: Behçet's disease (BD) is a chronic immune-mediated inflammatory disorder involving multiple organ systems. In BD, intestinal ulcers can present as a refractory lesion capable of perforation, which makes the choice of treatment difficult. PATIENT CONCERNS: A 34-year-old male who was d...
Autores principales: | Yan, Zhe, Cui, Bei-Bei, Yu, Yong-Yang, Yin, Geng, Cen, Xiao-Min, Xie, Qi-Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831344/ https://www.ncbi.nlm.nih.gov/pubmed/30817580 http://dx.doi.org/10.1097/MD.0000000000014624 |
Ejemplares similares
-
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease
por: Emmi, Giacomo, et al.
Publicado: (2016) -
Diagnostic value of hemoglobin and neutrophil-to-lymphocyte ratio in Behcet Disease
por: Zhang, Zunni, et al.
Publicado: (2019) -
Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study
por: Desbois, Anne Claire, et al.
Publicado: (2016) -
Budd–Chiari syndrome associated to Behcet disease: An observational retrospective multicenter study in Morocco
por: Allaoui, Abire, et al.
Publicado: (2022) -
Analysis of the potential relationship between COVID-19 and Behcet’s disease using transcriptome data
por: Zhao, Zhibai, et al.
Publicado: (2023)